GENE ONLINE|News &
Opinion
Blog

Funding
Manufacturing
RESILIENCE Launches with an Aim to Overcome Limitations of Traditional Manufacturing
2020-11-25
Funding Immunology
D3 Bio Launches with $200 Million to Advance Precision Medicine in Oncology and Immunology Space
2020-11-22
Funding Solid Tumor
Elevation Oncology Raises $65 M to Repurpose Failed Drug for Genomically Defined Tumors
2020-11-20
Funding Drug Discovery Platform
Kira Launches with $46 Million to Combat Complement-Mediated Diseases
2020-11-15
Funding Cell Culture
Trailhead Biosystems Raises $6.6 Million in Series A Financing
2020-11-12
Funding Institute for Functional Medicine
Scorpion Therapeutics Scores $108 Million Series A Funding for Oncological Research
2020-10-28
Funding RNAi Therapeutics
Maryland Biopharma Raises $105 Million in Series D to Fund Development of RNAi Therapeutics
2020-10-24
Funding Inflammatory Bowel Disease
Boston Biotech, Alivio Receives Substantial Grant from U.S. DoD, a Second in Two Years
2020-10-08
Funding Heart Disease
Why is Bristol Myers Squibb Investing $13.1 Billion in MyoKardia?
2020-10-06
Funding
Dewpoint Snags Successful Series B to Target Lesser Known Cellular Compartments
2020-10-02
Funding AI
AI Powered Startup XtalPi Announces 300 Million Series C Funding
2020-09-30
Startups
Investors Back Seattle-Based Startup’s Novel Immuno-Oncology Program Targeting Solid Tumors
2020-09-26
R&D Inflammatory Disease
Roche Invests €380 Million on Inflammatory Disease Focusing Irish Biotech
2020-09-24
R&D
Merck Bets Big on Seattle Genetics for Two Oncology Drugs
2020-09-16
Deals Recursion
AI Drug Pioneer Recursion Pharma Raises $239 Million Led by Leaps By Bayer
2020-09-12
1 … 8 9 10 11
LATEST
Pfizer’s Q1 2024 Revenue Declines, Offset by Strong Performance of Non-COVID-19 Products
2024-05-03
Novo Nordisk Revises Outlook: Reports 24% Growth in Q1 2024 Sales, Reaching DKK 65.3 Billion
2024-05-03
UC Riverside Scientists Unveil RNA-based Vaccine Strategy, Potentially Avoiding Endless Booster Shots
2024-05-02
Lilly’s Q1 2024 Financial Report: Full-Year Revenue Outlook Raised by $2 Billion, with a 67% Net Income Increase
2024-05-02
Taiwan Breakthrough: Next-Generation Sequencing Now Covered in Health Insurance, Benefitting 20,000 Cancer Patients Annually
2024-05-02
CellTech Accelerator and Cyto-Facto Inc. Forge Strategic Partnership to Advance CGT Industry Growth
2024-04-29
Kaiser’s Data Breach: 13.4 Million Affected in Healthcare Conglomerates Privacy Crisis
2024-04-26
READ MORE
EVENT
SEE MORE
Newsletter

Subscribe to receive updates.

SIGN UP
Facebook
Youtube
Twitter
Linkedin
About
Explore
More
© 2024 GeneOnline
Privacy Policy | Terms of Service
Privacy Policy | Terms of Service
  • Subscribe to our newsletter and dive into the world of biopharma with us.
SIGN UP
x
Scroll to Top